Brazil's Drug Market Set For Steady Growth

May 2006 | Industry Forecast

As regards international trade performance, BMI expects Brazil's pharmaceuticals deficit to widen over the forecast period. With the value of hi-tech imports only likely to grow, strenuous government-backed efforts to boost exports are not expected to improve Brazil's trade outlook significantly. Nevertheless, exports are likely to follow a steady upward trend, as both local industry and foreign companies invest in export capabilities in bids to exploit the benefits of the weak real and look outside the local market to maintain profit levels. Domestically produced medicines are currently very competitively priced, and the depressed value of the real affords producers -

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.